Détection et différenciation en 45 minutes de Clostridioïde difficile et de la souche épidémique 027
Xpert® C. difficile
Détection de Clostridioïde difficile en 40 minutes*
Le besoin
The alarming rise in the incidence of Clostridium difficile infection (CDI) highlights the need for rapid and accurate diagnostic solutions:
- Sensitivity of current available rapid diagnostic tests are unacceptably low1
- Additional length of stay increase caused by C. difficile infection is 5,6 days1
- Incremental costs due to C. difficile infection can be as high as $7 1791 per patient
- Testing of all suspected CDI cases directly with PCR is cost effective2
(1) Sloan L, et al. Comparison of Real-Time PCR for Detection of the tcdC Gene With Four Toxin Immunoassays and Culture in Diagnosis of Clostridium Difficile Infection. J Clin Microbiol. 2008 Jun; 46(6): 1996–2001. Accessed May 2020.
(2) Larson AM, et al. Evaluation of tcdB Real-Time PCR in a Three-Step Diagnostic Algorithm for Detection of Toxigenic Clostridium Difficile. J Clin Microbiol. 2010 Jan; 48(1): 124–130. Accessed May 2020.
* With early assay termination (EAT) for positive results.
La solution
Today’s testing methodologies have forced clinicians to choose between solutions that deliver either speed or accuracy. Cepheid’s Xpert® C. difficile delivers both in just 40 minutes:
- Superior test accuracy eliminates the need for additional or repeat testing
- Testing of all suspected CDI cases directly with PCR is cost effective2
- Rapid identification of infected patient helps infection control efforts
- Timely reporting enables clinicians to administer appropriate therapy thereby improving patient management
Cepheid’s Xpert C. difficile test provides on-demand results you can trust and empowers your clinical team to better manage patients.
Informations sur la commande
Xpert® C. difficile
Nombre de tests : 10
N° de réf. : GXCDIFFICILE-10Xpert® C. difficile
Nombre de tests : 120
N° de réf. : GXCDIFFICILE-120
